NCT00426478View on ClinicalTrials.gov

Safety and Efficacy of Valsartan Plus Hydrochlorothiazide and Amlodipine in Hypertensive Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

November 30, 2006

Study Completion Date

September 30, 2007

Conditions
Hypertension
Interventions
DRUG

Valsartan plus Hydrochlorothiazide (80mg/12.5mg)

DRUG

Amlodipine (5mg)

Trial Locations (1)

100

National Taiwan University, Taipei

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY